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ABSTRACT 
Objective: To compare the efficacy and the effect of the oxidative stress of Calcium Channel Blocker (CCB), Amlodipine and Angiotensin Converting 
Enzyme (ACE) inhibitor, Ramipril in the hypertensive patients of North East India. 
Methods: It is a prospective randomized controlled parallel study of the clinically used antihypertensive drug. Total 75 subjects were included in 
the study. Out of 75 subjects, 25 numbers were normal healthy subjects and remaining 50 were hypertensive patients. The patients were 
randomized and divided into two groups; Amlodipine treated group (n=25) and Ramipril treated group (n=25). Amlodipine group received 
Amlodipine (5-10) mg/day and Ramipril group received Ramipril daily (5-10) mg. All patients were newly detected hypertensive subjects suffering 
from essential hypertension without any prior antihypertensive therapy. Patients included were either sex (male/female) in age group of 20-65 y 
with normal fasting blood sugar level (FBS) and free from any other diseases. All groups was subjected to measurement of blood pressure, 
estimation of blood parameters like FBS, serum lipid profiles, serum glutamate pyruvate transaminase (SGPT) and serum glutamate oxaloacetate 
(SGOT) before antihypertensive treatment. The height, age, weight, health status and lifestyle pattern of patients were recorded. The patients were 
followed up during 8 w of antihypertensive treatment. Serum levels of glutathione (GSH), total antioxidant (TAS), superoxide dismutase (SOD) and 
malondialdehyde (MDA) levels were estimated before and after 8 w of antihypertensive therapy. 
Results: The present study indicated that both amlodipine and ramipril have significant effects on normalizing systolic and diastolic blood pressure 
(BP) after 8 w of treatment. Ramipril significantly reduced malondialdehyde (MDA) level and increased the serum levels of GSH, TAS and SOD 
during antihypertensive treatment. Ramipril reduces oxidative stress because of its antioxidant activity during antihypertensive therapy. 
Conclusion: Amlodipine and Ramipril are effective antihypertensive drugs. ACE inhibitor (Ramipril) has additional benefit of reducing oxidative 
stress thereby restoring the endothelial dysfunction in the hypertensive patient.  
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INTRODUCTION 
Hypertension is the leading cause of cardiovascular diseases in India 
and worldwide [1]. Cardiovascular diseases account for a large 
proportion of deaths and disability all over the world. It has been 
predicted that by the year 2020, there will be increased by almost 
75% in the global cardiovascular disease burden [2]. Hypertension 
is a common disorder if not effectively treated, results in a greatly 
increased probability of coronary thrombosis, renal failure, and 
stroke [3]. Hypertension is an independent risk factor for both 
coronary heart disease and stroke. High blood pressure is an 
important public health problem in India. High levels of superoxide 
anion, the consequent accumulation of hydrogen peroxide and 
diminished NO bioavailability play a critical role in the modulation 
of vascular remodeling [4, 5]. The reaction product between 
superoxide and NO constitutes a strong oxidant molecule which is 
able to oxidized protein, lipids, and nucleic acid and causing cell 
damage. These pathological processes are associated with 
hypertension because of narrowing arterial lumen, consequently to 
increase peripheral resistance and increase blood pressure (BP). 
Renin release from the kidney cortex is stimulated by reduced renal 
arterial pressure. Renin acts on angiotensinogen to split off the 
inactive decapeptide, angiotensin-I, which is then converted to 
angiotensin-II by endothelial angiotensin-converting enzyme [ACE]. 
Angiotensin-II is a vasoconstrictor and has sodium retention 
activity. So, peripheral resistance is increased. The ACE inhibitors 
block the ACE enzyme therefore, reduced peripheral resistance. 
Amlodipine is a newer second generation CCB and they have little 
interaction with other cardiovascular drugs. The intercellular 
concentration of calcium plays an important role in maintaining the 
tone of smooth muscle and in the contraction of the myocardium. 
Calcium enters muscle cells through special voltage sensitive 
calcium channels. This triggers the release of calcium from the 
sarcoplasmic reticulum and mitochondria, which further increases 
the cytosolic level of calcium. Calcium channel antagonists block the 
inward movement of calcium by binding to L-type calcium channels 
in the heart and smooth muscle of coronary as well as peripheral 
vasculature. These cause the vascular smooth muscle to relax, 
dilating mainly arterioles. 
Hypertension is a disease which continuously increasing in the 
population in India and worldwide. The study shows that genetically 
Indians are prone to develop hypertension much earlier than the 
western countries [6]. There is a diverse ethnic population with 
different lifestyle in North East Region. A very few studies are 
available about the prevalence of hypertension and control of 
hypertension in this northeast India [7, 8]. This present study was 
undertaken to investigate the efficacy of antihypertensive drug 
suitable for the patient suffering from essential hypertension of this 
region. Antihypertensive drug should have better efficacy and 
minimum side effect. The objective of the present study was to 
compare the efficacy of currently used antihypertensive drugs in the 
hypertensive patients of this region and also to investigate the effect 
of such agents on antioxidant status, serum lipid profiles and liver 
enzymes. Such clinical studies are very important to access the 
safety as well as better patient compliance. 
MATERIALS AND METHODS  
Study design 
It is a prospective randomized controlled parallel study of the 
clinically used antihypertensive drug. This study was conducted in 
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Assam and Department of medicine, Assam Medical College & 
Hospital, Dibrugarh, Assam. The study was conducted after getting 
approved by the Institutional Ethical Committee; Assam Medical 
College with the approval No.09/IP/475 dated 20.04.2009. 
Population 
This study population included male and female hypertensive 
patients in the age group of 20-70 y from the OPD of Assam Medical 
College & Hospital, Dibrugarh, Assam. The following data was 
obtained for each participant. 
1. Demographic data (weight, height, age, ethnicity)  
2. Taking history of patient 
3. Pre-existing medical conditions (history of hypertension, 
diabetes, or other chronic conditions) 
4. Social History (smoking, alcohol consumption, food habit, 
occupation) 
The health information and demographic were collected. Past 
medical history, social history and pre-existing medical conditions 
data were self-reported by the study participants. These data were 
also verified against information from the participant’s medical 
records to ensure the accuracy of the data. 
The present study comprised of three groups. One group was 
healthy subject and other two groups were essential hypertensive 
patient groups. This study included 75 subjects. Out of 75 subjects 
25 were normal human healthy volunteers (NHV) without history of 
smoking, alcoholism any other diseases taken as control and 50 
subjects were untreated hypertensive patients without any 
other diseases. Out of the 50 subjects, 25 subjects were treated with 
Ramipril 5 mg/day and rest 25 subjects were treated with 
Amlodipine 5 mg/day. The blood pressure was measured in lying 
down or sitting position at ease and then 4 ml blood was collected 
with prior consent from the patient. The samples were analyzed for 
estimation of serum level of lipid profile, SGOT, SGPT and total 
antioxidant status as reported methods. Patients were again checked 
up after 8 w during antihypertensive therapy and above tests were 
repeated. 
Method of blood collection and processing 
Venous blood was collected from the subjects under aseptic 
condition by venipuncture using 5 ml sterile disposable syringe and 
needle. About 4 ml of blood was collected. Serum was separated by 
centrifugation at 2000 rpm for 10 min at room temperature. The 
samples were stored at 4 °C before analysis and samples were 
analyzed on the same day of collection [9].  
Blood pressure measurement 
Blood pressure was recorded by the auscultatory method by using 
sphygmomanometer in the left arm in sitting position or lying down 
position.  
Estimation of superoxide dismutase 
The SOD enzyme level was measured in erythrocytes using photo-
oxidation method [10, 11]. 3 ml packed blood cells were lysed by the 
addition of equal volumes of cold de-ionized water. Hemoglobin was 
precipitated by the addition of chloroform: ethanol (1:5). This was 
diluted with 500 µl water, centrifuge at 3000 rpm for 15 min. The 
supernatant containing SOD was used for measurement of its 
activity. 0.88 ml riboflavin solution (1.3×10-5
Estimation of glutathione  
 M) in 0.01 M potassium 
phosphate buffer pH 7.5 was added to 66 µl O-dianisidine and 100 µl 
of clear supernatant, optical density was measured at 460 nm. Then 
cuvette containing reaction mixture was transferred to the 
illuminating box for 4 min. The optical density was re-measured. The 
change in optical density was determined. The SOD content was 
calculated from the standard graph. 
0.5 ml of 5% tricarboxylic acid solution was added to 0.5 ml of 
citrated blood to precipitate the proteins and centrifuged at 3000 
rpm for 20 min. To 0.1 ml of supernatant, 1 ml of sodium 
phosphate buffer (pH 8) and 0.5 ml of 5, 5-Dithiobis-2-nitro 
benzoic acid (DTNB) (39.6 mg in 100 ml of 1 % sodium citrate) 
were added. The absorbance of the yellow color developed was 
measured at 412 nm [12].  
Total antioxidant status  
Total antioxidant status in serum was determined by the method of 
a stable, free radical, 1, 1-diphenyl-β-picrylhydrazyl (DPPH) at a 
concentration of 0.2 mM in methanol [13].  
Lipid peroxidation activity 
The amount of lipid peroxidation products present in the serum 
samples were estimated by the thiobarbituric acid reactive 
substances (TBARS) method. The reactive malondialdehyde 
products were measured by using spectrophotometer method [14].  
Estimation of SGOT and SGPT levels  
SGOT and SGPT levels were assayed by a colorimetric method [15].  
Statistical analysis 
All the values were expressed as mean±SEM. The data were 
analyzed using ANOVA, Newman Koel method. In tests, the criteria 
for statistical significance were* P<0.05, **P<0.01 and***P<0.001. 
RESULTS 
Demographic data and clinical characteristics of pretreated ramipril 
and amlodipine groups were shown in table 1. Demographic data 
and clinical characteristics were not significantly differing from 
pretreated ramipril group from amlodipine pretreated group. 
Levels of SBP were much higher in all pretreated patient groups. 
After antihypertensive treatment for a period of 8 w, SBP were 
significantly reduced both antihypertensive drugs. The SBP were 
reduced more significantly (P<0.001) from 168.4±4.80 mmHg to 
146.8±3.44 mmHg in the ramipril-treated group and 160.7±3.38 
mmHg to 136±1.84 mmHg in amlodipine-treated group (table 2). 
DBP significantly reduced after antihypertensive treatment as 
compared to pretreatment values. DBP reduced significantly 
(P<0.001 from 95.9±1.64 mmHg to 82.95±2.66 mmHg in ramipril-
treated group and 95.25±1.14 mmHg to 83.0±0.74 mmHg in 
amlodipine-treated group (table 2). 
HDL levels were significantly (P<0.05) increased from 33.92±1.61 
mg/dl to 43.16±1.37 mg/dl after amlodipine treatment. Serum 
levels of total cholesterol, triglyceride, HDL and LDL were not 
significantly altered during the treatment with ramipril (table 3). 
SOD levels were very low in pretreated hypertensive groups. This 
indicates the antioxidant levels of SOD were utilized to scavenge the 
superoxide radicals in hypertensive condition. The SOD levels were 
significantly (P<0.001) increased during treatment of ramipril. The 
level of SOD was increased with clinical improvement ramipril 
treated group from 16.15±1.80 IU/ml to 33.12±2.66 IU/ml (table 4). 
Total antioxidant levels were low in pretreated patient groups but 
gradually increased with clinical improvement during treatment. 
Total antioxidant levels were significantly (P<0.001) increased from 
24.07±2.02 nmol/ml to 65.13±3.01 nmol/ml after treatment with 
ramipril (Table.4).  
GSH levels were very low in all untreated hypertensive patients. GSH 
levels were significantly (P<0.01) increased from 235.9±13.07 
nmol/ml to 472.49±21.80 nmol/ml after ramipril therapy for a 
period of eight weeks (table 4).  
MDA levels were significantly decreased during ramipril treatment 
(P<0.05) as compared to pretreatment values. It remained 
unchanged in case of amlodipine therapy. 
DISCUSSION 
High blood pressure is one of the important public health problems 
in India. If remain untreated, sustained hypertension is a risk factor 
for the development of cardiovascular diseases. Oxidative stress 
mediated by free radical reactive oxygen species ROS. It is a primary 
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or secondary cause of many chronic diseases, heart failure, stroke, 
coronary heart disease along with the impairment of renal function 
[16, 17]. The serious complications are not only the consequences of 
increased blood pressure but also related to the arterial endothelial 
dysfunction and accelerate the process of hypertension.  
SBP is controlled by the stroke volume of the heart and the stiffness 
of the arterial vessels. BP varies from moment to moment with 
respiration, exercise, meals, alcohol, tobacco, bladder distension, 
temperature and pain. It is also influenced by circadian rhythm, age 
and race. In the overall populations, mean SBP increases 
progressively throughout adult life in men and women. The present 
study showed that ramipril comparatively a better antihypertensive 
agent due to its dual mode of action. BP was also reduced during 8 w 
of amlodipine treatment (table 2).  
SOD is one of the important free radical scavenging enzymes present 
in the human body. This SOD catalyzes the dismutation of 
superoxide radicals to O2 and H2O2. 
Glutathione peroxidase (GSH) appears to have a major role in the 
prevention of oxidative stress; it may also be an important anti-
atherogenic antioxidant. Glutathione is a tripeptide comprised of 
glutamate, cysteine, and glyceine. GSH is present in mast cells where 
it functions as an antioxidant and protects cells from toxic effects of 
ROS. Glutathione peroxidase deficiency results in endothelial 
dysfunction combined with structural vascular abnormalities, such 
as increased peri-adventitial inflammation and collagen deposition 
surrounding the coronary arteries. Glutathione has been regulated 
by immune cell function. Glutathione peroxidase with 5-lipoxygenase 
might constitute a protective function of the enzyme, in addition to its 
antioxidant activity [22]. Enalapril and captopril enhance glutathione-
dependent antioxidant defenses [23]. In the present study, glutathione 
were estimated in hypertensive patients. GSH levels were very low in 
all untreated hypertensive patients. But the glutathione levels were 
significantly increased (P<0.01) in the ramipril-treated group as 
compared to pretreatment values (table 4). 
Study results showed that the 
enzyme was decreased in the hypertensive stage. It indicated that 
the enzyme level was nearly completely utilized to scavenge the 
superoxide radicals. Prevention of tissue damage due to intracellular 
superoxide requires elevation of intracellular SOD. ACE inhibitor 
increases antioxidant enzyme activity [18, 19]. The role of 
antioxidants in the cardio-vascular diseases is based on the premise 
that free radicals can injure arteries and also induce atherosclerosis 
by inducing fatty streaks resulting in atheroma. Several factors such 
as low food intake, nutrients mal-absorption and inadequate 
nutrient release from the liver, acute phase response, infection and 
an inadequate availability of carrier molecules may influence 
circulating antioxidant concentrations [20]. The previous study 
indicated that ramiprilat protects the vascular endothelium against 
free radical induced functional injury [21]. Present study result 
demonstrated that the total antioxidant levels were found to be 
significantly reduced in all hypertensive patients without 
antihypertensive treatment. Total antioxidant activity was 
significantly (P<0.001) increased with clinical improvement during 
ramipril treatment and improved antioxidant activity can correct the 
restoration of NO bioavailability and endothelial dysfunction.  
Hypertension is a state of increased free radical activity which 
injuries the endothelium conjugated dienes and lipid peroxides. 
MDA is an end product of fatty acid oxidation and is often used as an 
indicator of lipid peroxidation. Our present study result 
demonstrates that MDA levels were higher in all hypertensive 
patients without any treatment when compared to healthy subjects. 
MDA levels were decreased during ramipril treatment as compared 
to pretreatment values. It may result to beneficial effects in the 
restoration of NO bioavailability and endothelial function.  
Oxidation of LDL can injure myocardium during reperfusion in 
myocardial infarction. HDL is the smallest lipoproteins. HDL particles 
synthesize both from the liver and intestine. HDL transport cholesterol 
from the peripheral tissues to the liver for excretion. The measurement 
of HDL cholesterol provides valuable information for the assessment of 
coronary heart diseases. Amlodipine significantly increases the HDL 
levels of the hypertensive patients after treatment (table 3). 
 
Table 1: It shows the demographic data of pretreatment groups of ramipril and amlodipine 
Demographic data  NHV Ramipril treated Amlodipine treated 
Average age (years) 42.3±.1.93 49.3±2.45  46.44±3.03 
Average height (cm) 151.4±1.45 147.9±1.63 158.65±2.29 
Average weight (kg) 57.20±2.79 53.05±2.87 48.44±1.33 
All the values were expressed as mean±SEM (n=25). 
 
Table 2: It shows the effect of ramipril and amlodipine on the systolic blood pressure, diastolic blood pressure and fasting blood glucose 
levels of hypertensive subjects 
Parameter NHV Ramipril treated Amlodipine treated 
Pre After Pre After 
SBP(mmHg) 121.0±0.42  168.4±4.80 146.8±3.44*** 160.7±3.38 136±1.84*** 
DBP(mmHg) 80.55±0.41 95.9±1.64 83.0±0.74*** 98.96±1.021 87.04±0.95*** 
FBS (mg/dl) 86.55±2.18 95.35±2.13 91.0±1.36 86.28±2.10  88.23±1.02  
All the values were expressed as mean±SEM (n=25). Statistical significance was ***P<0.00 
 
Table 3: It shows the effect of ramipril and amlodipine on the total cholesterol, triglycerides, HDL, LDL, SGOT and SGPT of hypertensive 
subjects 
Parameter NHV Ramipril treated Amlodipine treated 
Pre after Pre After 
TC (mg/dl) 145.9±2.34 160.25±2.22 157.05±1.61 160.88±5.64 158.9±2.54 
Trig (mg/dl) 149.6±1.87 150.65±3.17 151.6±2.68 146.68±3.46 147.7±3.02 
HDL(mg/dl) 37.55±0.52 36.25±0.79 39.95±0.69 33.92±1.61 43.16±1.37* 
LDL(mg/dl) 78.44±2.07 93.34±1.94 86.09±1.62 88.40±1.33 86.81±1.63 
SGOT(IU/l) 25.35±1.08 32.35±1.56 27.50±1.17 27.48±1.57 29.4±1.82 
SGPT(IU/l) 26.75±1.42 33.25±1.48 29.20±1.15 28.64±1.67 30.5±1.63 
All the values were expressed as mean±SEM (n=25), *P<0.05 
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Table 4: It shows the effect of ramipril and amlodipine on the SOD, TAS, GSH and MDA levels of hypertensive subjects 
Parameter NHV Ramipril treated Amlodipine treated 
Pre After Pre After 
SOD(IU/ml) 69.38±2.47 16.15±1.80 33.12±2.66*** 16.93±1.39 22.92±.1.40 
TAS(nmol/ml) 92.96±3.78 24.07±2.02 65.13±3.01*** 27.93±1.16  35.70±1.07  
GSH(nmol/ml) 636.65±63.51 235.9±13.07 472.49±21.80** 327.68±17.68 374.48±16.98 
MDA 
(nmol/ml/hr) 
3.36±0.22 6.948±1.07 3.72±0.714*  6.66±0.52 5.05±0.49 
All the values were expressed as mean±SEM (n=25). Statistical significance were *P<0.05, **P<0.01 and ***P<0.001. 
 
CONCLUSION 
Both amlodipine and ramipril are effective antihypertensive drugs 
to normalize SBP and DBP. ACE inhibitor, Ramipril has a significant 
effect on reducing oxidative stress. Ramipril seems to be more 
effective in the management of essential hypertension because of 
improving endothelial dysfunction for its antioxidant activity. 
Antioxidants may decrease the incidence of disease. However, more 
human studies are required to establish the efficacy and safety of 
these agents. 
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